Educational tool for Hispanic medullary thyroid cancer patients
Part of Cancer clinical trials.
This study tests a culturally tailored educational tool to help Hispanic or Latino/a patients with medullary thyroid cancer and their caregivers make informed decisions. It aims to improve understanding and support for Spanish-speaking individuals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You identify as Hispanic or Latino/a
- You can read, write, and speak Spanish
- You have medullary thyroid cancer or are a caregiver for someone who does
- You are willing to sign a consent form to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a patient-and-caregiver decision guide to help you decide when to start or stop a new cancer drug, join a clinical trial, or continue active surveillance. It aims to make tough choices feel clearer and more supported.
This study is developing a tool to help women with endometrial cancer better understand their diagnosis and treatment options. If you join, you will help shape this educational resource for future patients.
This study tests a Spanish-language decision tool to help people with advanced ovarian cancer choose the best maintenance therapy after chemotherapy. It is for patients who can read or speak Spanish and are eligible for maintenance treatment.
This trial follows people with medullary thyroid cancer to better understand their experiences. You may join if you have this diagnosis, are 18 or older, and are not taking another experimental drug.
This study follows children and adults with medullary thyroid cancer (MTC) and/or MEN2 to better understand how the condition progresses over time. It may help doctors plan care in the future by collecting long-term health and lab information, not by giving a new treatment.
This study follows adults who have medullary thyroid cancer (MTC) to learn how the cancer behaves over time. It may help by improving future care and follow-up strategies for people with MTC.
Hear when a new Cultural Adaptation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.